Download Oncogenesis due to an imbalance between activity of

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Neurodegeneration wikipedia , lookup

Neuropharmacology wikipedia , lookup

Neuropsychopharmacology wikipedia , lookup

Transcript
BB20023:DNA: make, break, disease
Dr. MV Hejmadi, 2004-05
Oncogenesis
Oncogenesis due to an imbalance between activity of
1) Oncogenes: Genes known as proto-oncogenes
code for proteins that stimulate cell division; mutated
forms, called oncogenes, cause stimulatory proteins to
be overactive, with the result that cells proliferate
excessively.
ONCOGENES
Activation of proto-oncogenes
(transformation)
Transformations brought about in several
ways
• Viral insertion
• Chromosomal rearrangements
– Altered regulation
– Fusion genes
• Gene amplification : e.g. rat
neuroblastomas show a T-A mutation
resulting in a constitutively active
growth factor receptor
• Point mutations
• Loss of degradation signals
2) Tumor suppressor genes (TSGs) code for
proteins that inhibit cell division. Mutations can
cause the proteins to be inactivated and may thus
deprive cells of needed restraints on
proliferation.
BB20023:DNA: make, break, disease
Dr. MV Hejmadi, 2004-05
Oncogenes in cell signalling:
One of the ways cell behaviour is controlled is through the effects of polypeptide growth factors which
interact with membrane-bound glycoprotein receptors that transduce the message via a series of intracellular
signals that promote or inhibit the expression of specific genes. Cancer cells often show alterations in the
signal transduction pathways that lead to proliferation in response to external signals. E.g many growth
factor receptors, their membranes, cytoplasmic and nuclear downstream effectors have been identified as
oncogenes or tumour
suppressor genes. It is
the activation of
protooncogenes
and/or
the
inactivation
of
tumour
suppressor
genes that lead to
oncogenic
transformation
ONCOGENES
Genes for growth factors or their receptors
PDGF Codes for platelet-derived growth factor. Involved in glioma (brain cancer)
erb-B
Codes for the receptor for epidermal growth factor. Involved in
glioblastoma (brain cancer) and breast cancer
erb-B2 Also called HER-2 or neu. Codes for a growth factor receptor. Involved in
breast, salivary gland and ovarian cancers
RET
Codes for a growth factor receptor. Involved in thyroid cancer
Genes for cytoplasmic relays in stimulatory signaling pathways
Ki-ras
Involved in lung, ovarian, colon and pancreatic cancers
N-ras
Involved in leukemias
Genes for transcription factors that activate growth promoting genes
c-myc
Involved in leukemias and breast, stomach and lung cancers
N-myc Involved in neuroblastoma (a nerve cell cancer) and glioblastoma
L-myc Involved in lung cancer
Genes for other molecules
Bcl-2
Codes for a protein that normally blocks apoptosis. Involved in follicular B
cell lymphoma
Bcl-1
Also called PRAD1. Codes for cyclin D1, a stimulatory component of the
cell cycle clock. Involved in breast, head and neck cancers
MDM2
Codes for an antagonist of the p53 tumor suppressor protein. Involved
sarcomas (connective tissue cancers) and other cancers
References:
1) Chapter 7: Cellular & Mol. Biol by Knowles and Selby AND/OR
2) Chapter 6: Cancer Biology (2nd edition) by RJB King:
BB20023:DNA: make, break, disease
Optional reading: Oncogenes by Amanda Perry (www.els.net)
Dr. MV Hejmadi, 2004-05